These historical trial remission rates are astronomical.i wouldnt doubt it if company like celgene partners with them. Bisantrene is rock solid salavage therapy for AML. Time to load up and keep stock in your top drawer. And in 2 years you could be sitting on a pile of money. Do some research on celator $1 to. $32 bucks when jazz acquired them. Jazz should acquire these guys now. Before its game over...
48% remission rates in relapse refractory AML...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.050(3.13%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.70 | $1.52 | $318.0K | 193.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 496 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 5484 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |